ADE? Spellcheck destroys more meaning than it clarifies.

It's convenient to think that they have tried to create a lifelong dependency on injectables. I have relatives who are Type 1 diabetics who can tell you that, with no innovation in medication, the cost of insulin has shot through the roof. Except: crossing the border to Canada (note: the border is closed for 15 months now) buys the SAME medication at 1/15th the retail cost in the USA, I do not expect that the insulin makers are selling at a loss to Canada, just a small, regulated, 20-30% profit.

I'd expect the same with vaccines, especially now that Pfizer has announced that they will require booster shots, which looks like a permanent ~10 billion in added annual revenue, most of it profit. Capitalized at a p/e of 30, that might increase the value of the company by $300bln, and drive up those executive stock options.

But they won't get that gravy train internationally. $300bln in market cap might be incentive enough. This doesn't explain countries like France and others pushing the vaxx, however.